You likely know the expression, Pay It Forward. It’s an important concept for any kind of social awareness, but it can carry special meaning as well in the breast cancer world, particularly in research.
That’s because so much of today’s important breakthroughs are built not only on yesterday’s participation of other patients, but, of course, the work of other researchers.
It’s a sentiment Dr. Luca Gianni not only knows well, but also puts into practice every day.
As you’ll hear, in this important and engaging conversation, Dr. Gianni remains grateful to his mentor – Dr. Gianni Bonadonna – who brought him into the National Institute for the Study and Treatment of Cancer in Milan, Italy some 40 years ago. Based on what he learned there, Dr. Gianni has since delivered numerous breakthroughs in cancer research.
Onea main treatment – particularly in women with locally advanced or inflammatory HER2-positive breast cancer.
Now he is taking that same mindset – focus on early treatment – to drive his research in an important different direction: To help identify triple negative breast cancer patients most likely to benefit from checkpoint inhibitor therapy before beginning the treatment and those who will do well with chemotherapy alone. Not only would this help find patients with greater likelihood for an improved outcome, of course, but it also could help reduce the extreme costs and toxicity side effects for patients unlikely to benefit.
More about Dr. Gianni: He is Director of the Department of Medical Oncology and the head of the Project of Development of New Drugs and Innovative Therapies in Solid Tumors at the San Raffaele Scientific Institute in Milan. He is also Cofounder and President of the Michelangelo Foundation, a non-profit organization designed to advance research in oncology, and chairman of the Michelangelo Breast Cancer Study Group. Dr. Gianni has received several grants and research support, and was awarded the “Gianni Bonadonna Award and Fellowship” by the American Society of Clinical Oncology in 2011 – yes, an award named after his mentor. He also has been a BCRF Investigator since 2018.
I connected with Dr. Gianni in his lab in Italy, which left me envious of course that the conversation occurred, as you’ll hear, via computer, rather than in person – say, in a local Milan cafe… Well, we can’t have everything
The Urgent Need for Triple-Negative Breast Cancer Breakthroughs with Dr. Elisa Port
How Diet and Lifestyle Influence Your Breast Cancer Risk with Dr. Graham Colditz
BCRF’s 2021 Boston Hot Pink Symposium
Artificial Intelligence and the Future of Breast Cancer Research with Dr. Connie Lehman
Breaking Down Personalized Diagnostics in Breast Cancer with Dr. Joshua LaBaer
Understanding Global Breast Cancer Disparities with Dr. Temidayo Fadelu
Unraveling the Mysteries of Inherited Gene Mutations with Dr. Ephrat Levy-Lahad
Perfecting and Personalizing Risk Assessment with Dr. Katherine Nathanson
New Approaches to Reducing Repeat Breast Cancer Surgeries with Dr. Mehra Golshan
Improving the Quality of Life for Breast Cancer Patients and Survivors with Professor Dame Lesley Fallowfield
Understanding Radiation Resistance and Barriers to Quality Care with Dr. Lori Pierce
Connecting the Dots Between Breast Cancer Risk and Obesity, with Dr. Vared Sterns
BCRF Symposium and Awards Luncheon 2020
Improving National and Global Racial Disparities in Breast Cancer Care with Dr. Funmi Olopade
A Closer Look at the Evolution of Breast Cancer Cells with Dr. Kornelia Polyak
Exploring the Many Intersections of Health Equity in Latin America with Dr. Jeffrey Weitzel
Closing the Gap in Breast Cancer Care with Dr. Mariana Chavez MacGregor
The Promise and Potential of Breast Cancer Vaccines with Dr. Karen Anderson
The Underlying Biology of Drug Resistance with Dr. Sarat Chandarlapaty
A Cross-disciplinary Approach to Breast Cancer Research with Dr. Antonio Wolff
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
Exercise: Learn To Love (Or At Least Like) It
NASACast Video